Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection

Jpn J Infect Dis. 2000 Dec;53(6):244-5.

Authors

Y Yamamoto¹, A Yasuoka, C Yasuoka, I Genka, K Teruya, Y Kikuchi, N Tachikawa, S Oka

Affiliation

¹ AIDS Clinical Center, International Medical Center of Japan, Tokyo 162-8655, Japan.

PMID: 11227023

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-HIV Agents / adverse effects*
Anti-HIV Agents / therapeutic use
Antiretroviral Therapy, Highly Active / adverse effects
Didanosine / adverse effects
Didanosine / therapeutic use
Drug Therapy, Combination
Fatal Outcome
Granulocyte Colony-Stimulating Factor / therapeutic use
HIV Infections / blood
HIV Infections / complications*
HIV Infections / drug therapy
HIV-1*
Humans
Leukopenia / chemically induced*
Leukopenia / drug therapy
Male
Middle Aged
Nevirapine / adverse effects*
Nevirapine / therapeutic use
Reverse Transcriptase Inhibitors / adverse effects
Reverse Transcriptase Inhibitors / therapeutic use
Zidovudine / adverse effects*
Zidovudine / therapeutic use

Substances

Anti-HIV Agents
Reverse Transcriptase Inhibitors
Granulocyte Colony-Stimulating Factor
Zidovudine
Nevirapine
Didanosine